Membrane contact sites (MCS) are zones of contact between the membranes of two organelles. At MCS, specific proteins tether the organelles in close proximity and mediate the nonvesicular trafficking of lipids and ions between the two organelles. The endoplasmic reticulum (ER) integral membrane protein VAP is a common component of MCS involved in both tethering and lipid transfer by binding directly to proteins containing a FFAT [two phenylalanines (FF) in an acidic tract (AT)] motif. In addition to maintaining cell homeostasis, MCS formation recently emerged as a mechanism by which intracellular pathogens hijack cellular resources and establish their replication niche. Here, we investigated the mechanism by which the Chlamydia-containing vacuole, termed the inclusion, establishes direct contact with the ER. We show that the Chlamydia protein IncV, which is inserted into the inclusion membrane, displays one canonical and one noncanonical FFAT motif that cooperatively mediated the interaction of IncV with VAP. IncV overexpression was sufficient to bring the ER in close proximity of IncV-containing membranes. Although IncV deletion partially decreased VAP association with the inclusion, it did not suppress the formation of ER-inclusion MCS, suggesting the existence of redundant mechanisms in MCS formation. We propose a model in which IncV acts as one of the primary tethers that contribute to the formation of ER-inclusion MCS. Our results highlight a previously unidentified mechanism of bacterial pathogenesis and support the notion that cooperation of two FFAT motifs may be a common feature of VAP-mediated MCS formation. Chlamydiahost cell interaction therefore constitutes a unique system to decipher the molecular mechanisms underlying MCS formation. endoplasmic reticulum-Chlamydia inclusion membrane contact sites | IncV | FFAT motif | VAP proteins | tether
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By definition, MCS can only occur, and perform their respective functions, if the two organelles are brought together and maintained in close apposition. This process is proposed to rely on specific tethering molecules that should in theory fulfill the following requirements: (i) be enriched at the point of contact between the two organelles; (ii) be part of a molecular complex that bridges the opposing membranes; (iii) regardless of redundancy, their overexpression should increase the extent of contact; and (iv) if not redundant, their deletion should abolish the contact between the two organelles (2, 4) . Once contacts are established, functional proteins-such as lipid transfer proteins or ion channels-can initiate the exchange of molecules between the paired organelles. However, it is often difficult to discriminate between tethering and functional components, as their roles are not mutually exclusive. For example, the lipid transfer protein STARD3 has been implicated in both tethering endosomes to the ER and transferring cholesterol between these two organelles (5, 6) . In addition, because of redundancy, few molecules fulfill all of the tethering molecule criteria listed above. This is probably best illustrated by the fact that, in yeast, ER-PM contact sites were only lost after deletion of six tethering proteins (7) .
The ER integral proteins VAPA and VAPB [vesicle-associated membrane protein-associated protein, referred to as VAPs here (8) ] are common components of the MCS formed between the ER and various organelles (5, (9) (10) (11) (12) (13) (14) . At each of these MCS, VAPs interact with different proteins that have a 7-aa sequence, known as a FFAT motif [two phenylalanines (FF) in an acidic tract (AT)] in common (15) . The interaction between the FFAT motifcontaining proteins and the VAPs is mediated by the binding of the FFAT motif to electropositive residues in the cytosolic MSP (major sperm protein) domain of the VAP proteins (16, 17) . Many of the VAP-interacting proteins are lipid transfer proteins, including CERT (ceramide transfer protein) (18) and OSBP Significance Direct interorganelle contact, without fusion and through the formation of membrane contact sites (MCS), is crucial to maintain cell homeostasis and is exploited by intracellular vacuolar pathogens to establish their replication niche. At MCS, specific proteins are involved in the exchange of lipids and ions between the two organelles, but also in tethering the membranes of the partnering organelles in close apposition. Here, we describe how Chlamydia trachomatis, the leading cause of sexually transmitted diseases of bacterial origin, has evolved eukaryotic molecular mimicry to tether the endoplasmic reticulum to the pathogen-containing vacuole. Our work highlights a previously unidentified mechanism of bacterial pathogenesis in particular, and highlights conserved features of MCS biology in general.
(oxysterol-binding protein) family members (19) , which can also act as tethering factors through their interaction with the VAPs.
Pathogen-containing vacuoles resemble cellular organelles: they have a unique protein and lipid composition and their maturation requires interaction with other cellular organelles. This is a pathogen-driven process. One common strategy that pathogens employ is to translocate bacterial effector proteins across the vacuolar membrane to manipulate the vesicular trafficking of the host cell (20) . In particular, the obligate intracellular bacterium Chlamydia trachomatis, which resides in a membranebound compartment, termed the inclusion, intercepts the vesicular trafficking between the Golgi and the PM to acquire sphingomyelin, a host lipid that is incorporated into the cell wall of the bacteria and is essential for bacterial replication (21) (22) (23) . In addition to vesicular trafficking, the C. trachomatis inclusion also establishes MCS with cellular organelles, such as the ER (24, 25) . These ER-inclusion MCS are highly enriched in two known components of ER-Golgi MCS, the lipid transfer protein CERT, which mediates the nonvesicular transfer of ceramide from the ER to the Golgi, and the VAPs (8, 18, 24, 26) . IncD, a member of the family of C. trachomatis type III translocated effector proteins that are inserted into the inclusion membrane (i.e., the Inc proteins) (27) (28) (29) , also localizes to ER-inclusion MCS and recruits CERT to the inclusion (24) . The IncD/CERT/VAP complex has been proposed to mediate the transfer of lipids to the inclusion, a process necessary for bacterial replication (24, 26) .
Although we have started to gain insight into the functional role of ER-inclusion MCS in lipid exchange, it is still unclear how the ER is recruited and maintained in close apposition to the inclusion membrane. Here we show that, through molecular mimicry of eukaryotic FFAT motifs, the C. trachomatis protein IncV is one of the primary molecular tethers that contributes to the formation of ER-inclusion MCS through interaction with the ER-resident proteins VAPA and VAPB.
Results
IncV-VAP Interaction Depends on the FFAT Binding Domain of VAP.
C. trachomatis Inc proteins all share a common predicted structure, including at least two to four transmembrane domains (30) for insertion into the inclusion membrane and amino-and carboxylterminal cytosolic tails. Inc proteins are strategically positioned to mediate inclusion interaction with cellular organelles. For example, IncD mediates the recruitment of the functional component CERT to ER-inclusion MCS (24) . However, it is unknown if Inc proteins can also act as structural components to bring and maintain the ER and the inclusion membrane in close apposition. C. trachomatis encodes more than 50 putative Incs and only some of them have known functions in C. trachomatis infection (24, 28, (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) . Recently, Mirrashidi et al. (37) determined the Inc-human interactome from uninfected cells expressing C. trachomatis Inc proteins. Interestingly, the Inc protein CT005, that we have renamed IncV (Inc interacting with VAP) based on our findings, was predicted to interact with the ER-resident proteins VAPA and VAPB, which are both enriched at ER-inclusion MCS (24, 26) . To validate that IncV interacts with VAPA and VAPB, we subjected lysates from HEK293 cells expressing IncV-3xFLAG and GFP-VAPA or GFP-VAPB to coimmunoprecipitation (co-IP) using anti-FLAG conjugated beads. VAPA WT coimmunoprecipitated with IncV ( Fig. 1A ) and a similar result was obtained with VAPB WT (Fig. S1A ). The IncV-VAP interaction was specific and not due to aggregation of IncV in the ER (Fig. S2A ). Importantly, mutant forms of VAPA and VAPB, with a defective FFAT binding domain (VAP KFM/DFD ), failed to co-IP with IncV ( Fig. 1A and Fig. S1A ). Thus, when expressed in eukaryotic cells, IncV interacts with VAPA and VAPB in a manner that relies on the integrity of the FFAT binding domain of VAP.
IncV Contains Two FFAT Motifs That Mediate IncV-VAP Interaction.
Based on the hydropathy profile of IncV ( Fig. S2B) , it is predicted that the N-terminal region of IncV (amino acids 1-166) contains the type III secretion signal and the hydrophobic domain important for insertion into the inclusion membrane. The C-terminal region of IncV (amino acids 167-363) is predicted to face the cytosol. Additionally, analysis of the primary sequence of IncV and of the other C. trachomatis Incs, using an algorithm designed by Murphy and Levine (44) , revealed the presence of two putative FFAT motifs, in the C-terminal (cytosolic) region of IncV only ( Fig. 1B , amino acids 252-296 are shown). Both motifs are preceded by a stretch of serine residues which, if phosphorylated, could provide the acidic environment typically located upstream of the consensus FFAT sequence [E 1 (F/Y) 2 (F/Y) 3 D 4 A 5 x 6 E 7 ]. One FFAT motif (SFHTPPN, amino acids 262-268) is quite degenerated compared with the consensus sequence, except for the phenylalanine residue at position 263, and will be referred to as the IncV noncanonical FFAT motif (ncFFAT). The other FFAT motif (EYMDALE, amino acids 286-292) is located 17 aa downstream of the ncFFAT. Its sequence is nearly identical to the consensus sequence and will be referred to as the IncV canonical FFAT (cFFAT). This result suggests that FFAT motifs present in IncV may promote IncV interaction with VAPA and VAPB.
While amino acid substitutions are tolerated at most positions in the FFAT motif, a phenylalanine or a tyrosine residue at position 2 is critical for VAP binding (44) . To test the functional importance of the putative FFAT motifs in IncV, we introduced alanine substitutions in the essential position 2 of the ncFFAT (F263A), the cFFAT (Y287A), or both FFAT motifs (F263A-Y287A, referred to as FY/AA). The ability of GFP-VAP to co-IP with the indicated IncV-3xFLAG constructs was assayed, after confirming that these constructs did not aggregate ( Fig. S2A ). VAPA WT (Fig. 1C ) and VAPB WT (Fig. S1B ) successfully coimmunoprecipitated with IncV WT and IncV F263A , but not with IncV Y287A and IncV FY/AA . These results indicate that IncV-VAP interaction requires an intact cFFAT motif, but the ncFFAT is apparently dispensable.
The MSP Domain of VAP and the C Terminus of IncV Mediate IncV-VAP Interaction. To demonstrate that IncV interacts with VAPA in an in vitro system, we performed GST pull-down assays. The MSP domain of VAPA, which contains the FFAT binding domain, was expressed as a GST-tagged fusion protein in Escherichia coli, immobilized on glutathione Sepharose beads, and incubated with cell lysates from eukaryotic cells expressing IncV-3xFLAG full-length (amino acids 1-363) or the C-terminal part of IncV that contains the FFAT motifs (amino acids 167-363) ( Fig. 1D ). VAPA MSP-WT successfully pulled down IncV 1-363-WT and IncV 167-363-WT . However, mutations in either the FFAT binding domain of VAPA (KFM/DFD) or the FFAT motifs of IncV (FY/AA) abolished this interaction. Thus, the MSP domain of VAP and the C terminus of IncV are sufficient to support the IncV-VAP interaction, which neither relies on insertion of the proteins into the inclusion membrane nor requires additional C. trachomatis factors. We cannot exclude, however, that additional eukaryotic factors may be required.
IncV-VAP Interaction Occurs During C. trachomatis Infection. To validate our observations in the context of infected cells, we engineered C. trachomatis strains expressing mCherry constitutively, and IncV-3xFLAG (WT, F263A, Y287A, or FY/AA) under the control of an anhydrotetracycline (aTc)-inducible promoter. All four IncV constructs were expressed upon the addition of aTc and localized to the inclusion membrane ( Fig. 2 and Fig. S2C ). When cells expressing GFP-VAPA WT or GFP-VAPA KFM/DFD were infected with the IncV WT -3xFLAG-expressing C. trachomatis strain, VAPA WT , but not VAPA KFM/DFD , coimmunoprecipitated with IncV WT ( Fig. 2A) . Moreover, while VAPA WT also coimmunoprecipitated with IncV F263A , it failed to do so with IncV Y287A or IncV FY/AA (Fig. 2B) . A similar result was obtained with VAPB (Fig. S1 C and D). Altogether, these results show that IncV proteins, produced by C. trachomatis and inserted into the inclusion membrane, interact with VAPA and VAPB in a manner that relies on the FFAT binding domain of VAP and the cFFAT motif of IncV.
IncV-Mediated Association of VAP with the Inclusion Depends on the FFAT Binding Domain of VAP. We next investigated the cellular localization of YFP-VAPA in cells infected with a C. trachomatis strain expressing the inducible IncV WT -3xFLAG. In the absence of inducer, small patches of VAPA WT were observed in close apposition to the inclusion (Fig. 3A) . Upon the addition of aTc, IncV WT localized to the inclusion membrane, which correlated with an increased recruitment of VAPA WT to the inclusion and with colocalization of IncV and VAPA on the inclusion ( Fig. 3 A  and D) . IncV WT expression, however, did not induce an increase in recruitment of VAPA KFM/DFD to the inclusion ( Fig. 3 B and D) . Similar results were observed with VAPB ( Fig. S4 A, B, and D) .
These results indicate that IncV mediates the recruitment of VAP to the inclusion and that this recruitment requires an intact FFAT binding domain in the VAP molecule.
Both FFAT Motifs of IncV Are Required for VAP Association with the Inclusion. We next tested whether the FFAT motifs of IncV are required for VAP association with the inclusion. As observed with IncV WT , inclusions harboring C. trachomatis expressing IncV F263A or IncV Y287A displayed increased association with VAPA WT , compared with the uninduced control ( Fig. 3C ). Expression of IncV FY/AA , however, did not induce an increase in the association of VAPA with the inclusion. Quantification of the immunofluorescence data revealed that, individually, the introduction of F263A and Y287A mutations reduced VAPA recruitment to the inclusion by 60% compared with their WT counterpart. The combination of these mutations (FY/AA) had an additive effect, leading to a reduction of nearly 95% (Fig. 3E ). A similar result was observed with VAPB WT (Fig. S4 C and E) . Altogether, these results indicate that IncV promotes VAP recruitment to the C. trachomatis inclusion and that both IncV ncFFAT and cFFAT motifs contribute to this process.
IncV Promotes the Formation of ER-Inclusion MCS in a VAP-Dependent Manner. To determine if IncV could recruit the endogenous ER-resident VAP proteins to the inclusion membrane, HeLa cells infected with a C. trachomatis strain expressing the inducible IncV WT -3xFLAG construct were immuno-labeled with anti-VAPA antibodies (Fig. 4A ). In the absence of inducer, endogenous VAPA localized to discrete patches in close proximity to the inclusion. However, when the expression of IncV WT was induced, endogenous VAPA strongly accumulated on the surface of the inclusion. These results indicate that IncV can recruit the endogenous ER-resident protein VAPA to the inclusion membrane and possibly the ER associated with this protein. In support of this notion, qualitative ultrastructural analysis of C. trachomatis inclusions harboring the inducible IncV WT -3xFLAG strain, in the absence of inducer, revealed the recruitment of ER-like membrane structures closely apposed to the inclusion membrane (see Fig. 4B and Fig. S5 for larger images), as previously described (24) . The extent of the ER-like membrane structures was greatly increased when IncV WT expression was induced, with long and continuous membrane tracks tightly apposed to the inclusion membrane. The ER nature of the tracks was further confirmed by analyzing the cellular localization of the ER marker Sec61β by confocal microscopy. Sec61β + rings that colocalized with IncV surrounded 80% of the inclusions harboring the inducible IncV WT strain (see Fig. 4 C and D and Fig. S6A for larger images of the Sec61β marker). In cells treated with siRNA against VAPA and VAPB, however, the percentage of inclusions presenting a Sec61β + ring was reduced by 65%, which also translated into a reduction of the Sec61β signal associated with IncV ( Fig. 4E ). Taken together, these results indicate that IncV promotes the formation of ER-inclusion MCS and that VAPA and VAPB are required for this process.
PM-Targeted IncV Tethers the ER to the PM.
To determine if IncV is sufficient to mediate the formation of MCS between the ER and other cellular membranes in the absence of Chlamydia infection, we targeted the C-terminal cytosolic tail of IncV to the PM, by fusion of a C-terminal CAAX motif (PM-IncV 167-363 -3xFLAG) (Fig. S7A) . In cells expressing the cytosolic IncV 167-363-WT , VAPA WT displayed the typical reticulate pattern of the ER (Fig.  5A, Top) . A similar VAPA pattern was observed upon expression of a PM-targeted red fluorescent protein (Fig. S7B) . Expression of PM-IncV 167-363-WT , however, dramatically affected the cellular localization of VAPA WT and induced the formation of large sheets that were plastered against the PM and highly enriched in VAP and PM-IncV (Fig. 5A, Middle) . The sheets were positive for the ER marker CFP-ER (Fig. 5B ), but were not observed when the FFAT motifs of IncV were mutated (FY/AA) ( Fig. 5A, Bottom) . Altogether, these results indicate that, independent of the lipid and protein environment of the inclusion membrane, expression of PMtargeted IncV induces the formation of ER-PM MCS.
An IncV Mutant Displays MCS with Reduced Level of VAP. Finally, we tested if IncV is required for the formation of ER-inclusion MCS by using an incV::bla mutant (43) . We confirmed that the mutant harbors an intron insertion between nucleotide position 99 and 100 of the incV ORF, which is predicted to lead to the production of a truncated peptide containing the first 33 aa of IncV ( Fig. S8 A  and B) . Moreover, as previously shown by Weber et al., the incV:: bla mutant did not display a growth defect (Fig. S8C) . VAP + ER-inclusion MCS of similar volumes were observed in close apposition to inclusions harboring the incV::bla mutant or its WT counterpart ( Fig. 6 A and B) ; however, the mutant displayed a significant, albeit moderate, reduction in the levels of YFP-VAP enrichment at the MCS (Fig. 6C ). In sum, our data indicate that IncV is sufficient, but not necessary, for the formation of ERinclusion MCS, suggesting the existence of redundant mechanisms.
Discussion
Here, we report a bacterial factor containing eukaryotic FFAT motifs. We present evidence that both motifs are required for IncV interaction with the ER-resident proteins VAPA and VAPB and that the IncV-VAP interaction contributes to the formation of ER-inclusion MCS. FFAT motifs were first described as a 7-aa sequence (EFF-DAxE) that targets eukaryotic proteins to the ER through interaction with the ER-resident VAP proteins (15) . The sequence of IncV cFFAT (EYMDALE) is nearly identical to the consensus FFAT motif and key residues that have been shown to mediate the FFAT/VAP interaction are conserved (16, 17, 45) . IncV cFFAT includes the invariable aromatic residue (phenylalanine or tyrosine) at position 2, which has been shown to establish van der Waals interaction with VAPA residue methionine 89. Accordingly, mutation of this critical aromatic residue at position 2 of the cFFAT motif of IncV was sufficient to abolish the IncV-VAP interaction. Moreover, substitution of methionine 89 (and lysine 87) in VAP KFM/DFD abolishes VAP interaction with FFAT-containing proteins, including IncV. The cFFAT of IncV also displays the conserved aspartate residue at position 4. Structural analysis of VAP bound to the FFAT motif of OSBP revealed that this aspartate residue formed an electrostatic interaction with lysine 34 and lysine 45 present in the electropositive face of the MSP domain of VAPA (17) . In addition, alanine substitution of aspartate residue at position 4 in the FFAT motif of Osh1, CERT, and protrudin abolished the interaction of each protein with VAP (9, 15, 46) , further illustrating the importance of these conserved residues for FFAT-VAP interaction. As previously described for the FFATlike motif of ORP3 (HFFSGST) and STARD3 (QFYSPPE), the ncFFAT of IncV (SFHTPPN) is more divergent from the canonical sequence (5, 47) . Nevertheless, it displays the aromatic residue at position 2 and, like in ORP3 and STARD3, position 4 harbors a serine or threonine residue that could be phosphorylated and therefore mimic the aspartate residue present in the canonical sequence. Altogether, the level of mimicry displayed by the FFAT motifs of IncV is striking and each motif, especially the cFFAT, contains the key residues that have been experimentally confirmed to promote interaction with the VAP proteins.
Another hallmark of the FFAT motif is the presence of upstream acidic residues, such as aspartate and glutamate, or negatively charged residues, such as phosphorylated serine and threonine residues (15) . On average, four acidic residues are present upstream of any given FFAT motif (44, 47) , but strikingly, IncV ncFFAT and cFFAT motifs are each directly preceded by multiple serine residues, which, if phosphorylated and combined with the acidic residues also present upstream of the FFAT motifs, would offer unprecedented tracts of nine and eight consecutive negatively charged residues, respectively ( Fig. 1B) . If, as proposed, the acidic tract plays a role in increasing VAP binding by mediating the formation of the intermediate FFAT-VAP complex via electrostatic interactions (17) , it would suggest that the molecular mimicry displayed by C. trachomatis goes beyond the presence of FFAT motifs and also includes an accessory mechanism that ensures strong binding to VAP.
Many of the FFAT motif-containing proteins characterized to date are lipid transfer proteins of the CERT and OSBP-related proteins (ORP) family. Until recently, it was assumed that each of these proteins harbor a single canonical FFAT motif that interacts with the electropositive face of the MSP domain of the VAP proteins, thus mediating the interaction with the ER. However, Weber-Boyvat et al. (47) identified and characterized a second FFAT-like motif upstream of the canonical FFAT motif in ORP3. This observation led to the identification of many more putative FFAT-like motifs upstream of the canonical FFAT motif of known VAP-interacting proteins (44, 47) . Although the functionality of these FFAT-like motifs remains to be tested experimentally, data gathered for ORP3 validated the importance of the FFAT-like motif, by demonstrating that although mutation of the FFAT motif decreased VAP binding by 40%, mutation of both the FFAT and the FFAT-like motifs of ORP3 were required to completely abolish ORP3-VAP interaction, indicating that both motifs acted in synergy for VAP binding (47) . Similarly, the results presented here with IncV show that although the ncFFAT of IncV was dispensable for IncV-VAP interaction in a co-IP experiment in vitro, both motifs were required for VAP association with the inclusion in vivo. Altogether, these results reinforce the idea that cooperation of two FFAT motifs may be a common mechanism dictating the interaction of proteins with the VAP proteins.
At MCS, the membranes of the contacting organelles are brought and kept in close proximity by molecular tethers that meet the following criteria: (i) are enriched at the point of contact between the two organelles; (ii) are part of a molecular complex that bridges the opposing membranes; (iii) regardless of redundancy, their overexpression increases the extent of contact; and (iv) if not redundant, their deletion abolishes the contact between the two organelles (2, 4) . Our work demonstrates that the C. trachomatis inclusion membrane protein, IncV, fulfills three of the four criteria of a MCS tether. (i) IncV localizes to ER-inclusion MCS. (ii) IncV is inserted into the inclusion membrane and interacts with the ER-resident protein VAP. The IncV-VAP interaction therefore offers a molecular bridge that connects the inclusion membrane to the ER. (iii) IncV overexpression in C. trachomatis leads to augmented association of VAP with the inclusion, which correlates with an increase in the extent of the contacts between the inclusion membrane and the ER. Importantly, this occurs with an endogenous level of VAP. Moreover, IncV could also mediate the recruitment of the ER when targeted to the PM, which indicates that IncV can act independently of the lipid and protein environment, thus providing strong evidence that IncV is sufficient to mediate the formation of ER-inclusion MCS.
Although the incV mutant was partially impaired in VAP recruitment, incV deletion did not abolish the formation of ERinclusion MCS, suggesting that additional factors may be involved in MCS formation. Interestingly, we have shown that at ER-inclusion MCS, VAP also interacts with the lipid transfer protein CERT, which is recruited to the inclusion via interaction with IncD (34) . Thus, the IncD/CERT/VAP interaction could also provide some stability to the contacts, while being involved in lipid transfer (Fig. S9 ). This would be analogous to the STARD3/VAP interaction occurring at ER-endosome MCS, where the lipid transfer protein STARD3 mediates both the tethering of endosomes to the ER and the transfer of cholesterol between these two organelles (5, 6) . We note, however, that cooverexpression of all three components of the IncD/CERT/VAP complex was required for increased recruitment of VAP to the inclusion (34) . This is different from the present IncV-VAP interaction, which did not require VAP overexpression, suggesting a potent and direct role for IncV in VAP recruitment to the inclusion. Taking all of this together, we propose a model in which IncV is one of the primary tethers that contributes to the recruitment and association of the ER with the inclusion membrane.
Conclusion
Direct organelle contact, with no fusion occurring, is emerging as an important mechanism involved in interorganelle communication, and also in host-pathogen interactions. MCS are complex structures with a specific molecular signature that depends on the organelles involved, and deciphering the molecular components that control their formation and function is important to better understand their overall biology. The work presented herein illustrates how intracellular, vacuolar pathogens have evolved molecular mimicry of these components, thereby mediating the direct contact of the pathogen-containing vacuole with cellular organelles. Specifically, our data demonstrate that C. trachomatis displays on the surface of its inclusion a bacterial factor, IncV, that contains eukaryotic FFAT motifs required for the recruitment of the ER-resident protein VAP to the inclusion. Interestingly, as this report was under revision, it was shown that norovirus NS1-2 protein, a known VAP-interacting protein, also contains a FFAT motif (48) . Although the role of the NS1-2/VAP interaction remains to be determined, these observations suggest that viral and bacterial pathogens have coopted molecular mimicry of FFAT motifs to exploit the ER and establish their replication niche. Further characterization of the Chlamydia IncV-VAP system may not only shed light on the role of ER-inclusion MCS during Chlamydia pathogenesis, but also contribute to our understanding of the mechanism underlying organelle communication through formation of membrane contact sites.
Materials and Methods
HeLa cells, HEK293 cells, and C. trachomatis Lymphogranuloma venereum, type II were used in this study. For co-IP, precleared lysates were incubated with anti-FLAG M2 affinity beads and the protein-bound beads were eluted by competition with the 3xFLAG peptide. Imaging was performed using a spinning-disk confocal microscope equipped of an Andor iXon camera and driven by the IQ software. Quantification of inclusion association was performed using the Imaris imaging software. All genetic manipulations and containment work were approved by the University of Virginia Biosafety Committee and are in compliance with the section III-D-1-a of the NIH guidelines for research involving recombinant DNA molecules. Please see SI Materials and Methods for details about experimental procedures and reagents, and Dataset S1 for the primer pairs and corresponding templates used in this study.
